Skip to search boxSkip to navigationSkip to main content

Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules

  • John Sidney
    ,
  • Howard M. Grey
    ,
  • Scott Southwood
    ,
  • Esteban Celis
    ,
  • Peggy A. Wentworth
    ,
  • Marie France Del Guercio
*Corresponding author for this work
  • Cytel Corporation
    ,
  • La Jolla Institute for Allergy and Immunology
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

An HLA-A3-like supertype (minimally comprised of products from the HLA class I alleles A3, A11, A31, A*3301, and A*6801) has been defined on the basis of (a) structural similarities in the antigen-binding groove, (b) shared main anchor peptide-binding motifs, (c) the identification of peptides cross-reacting with most or all of these molecules, and (d) the definition of an A3-like supermotif that efficiently predicts highly cross-reactive peptides. Detailed secondary anchor maps for A3, A11, A31, A*3301, and A*6801 are also described. The biologic relevance of the A3-like supertype is indicated by the fact that high frequencies of the A3-like supertype alleles are conserved in all major ethnic groups. Because A3-like supertype alleles are found in most major HLA evolutionary lineages, possibly a reflection of common ancestry, the A3-like supermotif might in fact represent a primeval human HLA class I peptide-binding specificity. It is also possible that these phenomena might be related to optimal exploitation of the peptide specificity by human TAP molecules. The grouping of HLA alleles into supertypes on the basis of their overlapping peptide-binding repertoires represents an alternative to serologic or phylogenetic classification.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 79-93 (15 pages)

Journal (Volume, Issue Number)

Human Immunology (Volume 45, Issue 2)

Publication milestones

  • Published - 02/1996

Publication status

Published - 02/1996

ISSN

0198-8859

Publication IDs

  • Scopus: 0029933388
  • PubMed: 8882405

Publication metrics

Metrics

Scopus
citations
SciVal
citations
190
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
SciVal
FWCI
4.00
SciVal
Author count
9
SciVal
Paper percentile
98
SciVal
Top percentile
5

PlumX, opens in new tab

Captures
36
Citation count
188

Funding Details

FunderFunding number
NIAID
N01AI045241